Barry Flannelly

Director/Board Member presso PROTARA THERAPEUTICS, INC.

Patrimonio netto: 5 M $ in data 31/03/2024

66 anni

Health Technology

Consumer Services

Posizioni attive di Barry Flannelly

Società	Posizione	Inizio	Fine
INCYTE CORPORATION	Corporate Officer/Principal	01/08/2014	-
PROTARA THERAPEUTICS, INC.	Director/Board Member	23/07/2020	-
PROTARA THERAPEUTICS, INC.	Independent Dir/Board Member	23/07/2020	-

Società	Posizione	Inizio	Fine
GENOMIC HEALTH, INC.	Director/Board Member	16/04/2019	08/11/2019
OSS Healthcare, Inc.	Chief Executive Officer	01/08/2013	01/07/2014
NEKTAR THERAPEUTICS	Corporate Officer/Principal	01/04/2011	01/04/2013
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Corporate Officer/Principal	01/08/2008	01/01/2011
Johns Hopkins Oncology Center	Corporate Officer/Principal	-	-

Massachusetts College of Pharmacy & Health Science	Undergraduate Degree
University of Baltimore	Masters Business Admin
University of Maryland School of Pharmacy	Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	4
Director/Board Member	2
Doctorate Degree	1

Settori

Health Technology	6
Consumer Services	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	4
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Health Technology
Genomic Health, Inc. Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.	Health Technology
OSS Healthcare, Inc.
Johns Hopkins Oncology Center